-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Dalmitamig in Cutaneous Squamous Cell Carcinoma (cSCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dalmitamig in Cutaneous Squamous Cell Carcinoma (cSCC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dalmitamig in Cutaneous Squamous Cell Carcinoma (cSCC) Drug Details:...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Dalmitamig in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dalmitamig in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dalmitamig in Non-Small Cell Lung Cancer Drug Details: Dalmitamig (REGN-7075)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Dalmitamig in Head And Neck Squamous Cell Carcinoma (HNSC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dalmitamig in Head And Neck Squamous Cell Carcinoma (HNSC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dalmitamig in Head And Neck Squamous Cell...
-
Analyst Opinions
Net Zero by 2050 – Industrial Decarbonization Gains Momentum (Vol.2)
Net Zero by 2050 Overview Businesses and tech giants globally are focusing on low-carbon products, renewables, and EVs to achieve net zero emissions. Key sectors such as aerospace, automotive, and technology are advancing sustainability through innovations in hydrogen, EVs, fuel cells, and smart energy solutions among others. The “Net Zero by 2050” report outlines decarbonization-related deals value and volume trends, VC investment activity and geographic trends, and leading investors. The report also provides facts and figures related to climate change,...
-
Product Insights
Critical Care Ventilators Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Critical Care Ventilators Pipeline Market Report Overview Critical care ventilators are also known as intensive care ventilators. They provide artificial respiratory support to critical patients in ICUs. The critical care ventilators pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with...
-
Analyst Opinions
Sustainable Aviation Fuel – The Way Forward for Aviation Industry
Sustainable Aviation Fuel Report Overview There are currently 9 pathways for producing sustainable aviation fuel (SAFs), which are certified by the IATA. However, hydrotreatment remains the dominant pathway for the bulk of current SAF production. As SAF production increases, alternative pathways will become more prominent such as alcohol-to-jet (ATJ) and power-to-liquid (PtL) technologies. To spur emission reductions from the sector, organizations such as the ICAO and the ITAO have set a target of reaching net-zero emissions by 2050. Sustainable aviation...
-
Product Insights
NewVentilators Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Ventilators Pipeline Market Report Overview A ventilator is an artificial respiratory support device. It uses air pressure to deliver air into the lungs and alternatively, creates vacuum pressure to release carbon dioxide from it. The ventilators pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – REGN-5459 in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - REGN-5459 in Relapsed Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. REGN-5459 in Relapsed Multiple Myeloma Drug Details: REGN-5459 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – REGN-5459 in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - REGN-5459 in Refractory Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. REGN-5459 in Refractory Multiple Myeloma Drug Details: REGN-5459 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – REGN-5459 in Transplant Rejection
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - REGN-5459 in Transplant Rejection report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.REGN-5459 in Transplant Rejection Drug Details:REGN-5459 is under development for the treatment of...